They subsequently hypothesized that IFN is a central driver of immune dysregulation across diverse autoimmune diseases, advocated the therapeutic potential of IFN neutralization, and established a conceptual framework for IFN biology and its clinical targeting in autoimmunity [6,7]. The gene discussed is IFNA1; the disease is autoimmune disease.